5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The France Bariatric Surgery Market is segmented by Device (Assisting Devices, Implantable Devices, and Other Devices).
The French bariatric surgery market is expected to register a CAGR of 13.2% during the forecast period. The key factors propelling the growth of the market are the increase in obese patients and the prevalence rate of Type-2 diabetes and heart diseases.
As per the scope of the report, bariatric surgery is a medical procedure that aids weight loss by either limiting the capacity of the stomach or the absorption of the calories. This is the most effective weight loss therapy available for patients with morbid obesity, and it involves either open or laparoscopic techniques. The French bariatric surgery market is segmented by device (assisting devices, implantable devices, and other devices).
Report scope can be customized per your requirements. Click here.
The stapling devices segment is expected to show a comparatively higher growth rate over the forecast period, as compared to other devices used in bariatric surgeries. It is the most commonly used device, as it tends to result in greater and more consistent weight loss among patients, along with a greater reduction in obesity-related health problems. According to the Direction de la Recherche, des Études, de l'Évaluation et des Statistiques (DREES) and Agence technique de l'information sur l'hospitalisation (ATIH) 2016 report, in 2016, approximately 60,000 bariatric surgeries were performed in France. Thus, most of the bariatric procedures are currently being performed with mechanical stapling devices, thereby contributing to the overall growth.
To understand key trends, Download Sample Report
The French bariatric surgery market is consolidated and competitive. The manufacturers are innovating new technologies, which are non-invasive, for reducing patients’ time in the hospitals, decreasing the chances of infection, and saving the cost. Additionally, smaller players are implementing strategies, such as acquisitions, to expand their product portfolios and gain roots in the industry.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Obese Patients
4.2.2 Government Initiatives to Curb Obesity
4.3 Market Restraints
4.3.1 High Cost of Surgery
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Device
5.1.1 Assisting Devices
184.108.40.206 Suturing Device
220.127.116.11 Closure Device
18.104.22.168 Stapling Device
22.214.171.124 Clip Appliers
126.96.36.199 Other Assisting Devices
5.1.2 Implantable Devices
188.8.131.52 Gastric Bands
184.108.40.206 Electrical Stimulation Devices
220.127.116.11 Gastric Balloons
18.104.22.168 Other Implantable Devices
5.1.3 Other Devices
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Apollo Endosurgery Inc.
6.1.2 Ethicon Inc. (Johnson & Johnson)
6.1.3 Conmed Corporation
6.1.4 Covidien PLC (Medtronic PLC)
6.1.5 TransEnterix Inc.
6.1.6 B. Braun Melsungen AG
6.1.7 Olympus Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments